Bullish Moving Averages
9
Bearish Moving Averages
7
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
1007.10Today’s High
1047.4052W low
693.0052W High
1090.00Open Price
1034.00Prev. Close
977.8500Volume
117489.00Value
118892993.55Fundamentals
Market Cap
13770.10
Price to Earnings
35.10
Price to Book Value
4.30
Dividend Yield
0.00
PE to Growth
12.50
Op Revenue TTM
2009.14
Net Profit TTM
391.98
Cash From Operating Activity
486.01
Return on Equity %
15.15
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
55.1
Week
50.1
Month
48.7
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
1022.13
PIVOT
First Resistance
1037.17
Second Resistance
1062.38
Third Resistance
1077.42
First Support
996.92
Second Support
981.88
Third Support
956.67
Relative Strength Index
53.22
Money Flow Index
74.43
MACD
24.85
MACD Signal
30.96
Average True Range
36.58
Average Directional Index
30.03
Rate of Change (21)
10.31
Rate of Change (125)
10.76
Commodity Channel Index
-46.7
Williams %R
-90.6
BETA
1 Month
0.56
3 Month
0.18
1 Year
0.25
3 Year
0.08
PRICE CHANGE ANALYSIS
↓ -1.12%
1 Week
Low
High
1007.1
1090
↑ 3.49%
1 Month
Low
High
977
1090
↑ 18.86%
3 Months
Low
High
815.85
1090
↑ 8.46%
6 Months
Low
High
809.15
1090
↑ 43.34%
1 Year
Low
High
693
1090
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 361.69 | 327.85 | 416.68 | 415.31 | 318.84 | 335.49 | 361.52 | 332.13 | 291.19 | 310.47 | 330.31 | |
| Operating Expenses Qtr | 261.91 | 249.98 | 265.22 | 255.79 | 203.09 | 205.62 | 214.32 | 202.57 | 180.52 | 181.85 | 185.62 | |
| Operating Profit Qtr | 79.39 | 74.43 | 144.49 | 155.50 | 111.49 | 126.39 | 141.05 | 126.19 | 101.62 | 122.78 | 137.04 | |
| EBIDT Qtr Cr | 99.78 | 77.87 | 151.47 | 159.53 | 115.75 | 129.87 | 147.20 | 129.56 | 110.68 | 128.62 | 144.70 | |
| Depreciation Qtr | 29.14 | 28.08 | 25.00 | 20.16 | 17.28 | 16.50 | 15.90 | 14.97 | 15.07 | 13.54 | 11.62 | |
| Net Profit Qtr | 39.51 | 31.66 | 117.81 | 110.74 | 87.84 | 99.38 | 115.20 | 95.59 | 86.71 | 104.06 | 119.71 | |
| Basic EPS Qtr | 2.90 | 2.33 | 8.66 | 8.14 | 6.46 | 7.31 | 8.47 | 7.03 | 6.38 | 7.66 | 8.81 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 1521.53 | 1347.99 | 1244.72 | 1118.83 | 1034.96 | |
| Operating Expenses Annual Cr | 1032.89 | 825.61 | 731.74 | 691.52 | 664.63 | |
| Operating Profit Annual | 453.81 | 505.11 | 484.00 | 417.31 | 355.60 | |
| Operating Profit Margin Annual % | 29.83 | 37.47 | 38.88 | 37.30 | 34.36 | |
| Total Expenses Annual Cr | 1192.70 | 911.08 | 786.18 | 729.94 | 711.37 | |
| EBIDT Annual Cr | 488.64 | 522.38 | 512.98 | 427.31 | 370.33 | |
| EBIDT Annual margin % | 32.12 | 38.75 | 41.21 | 38.19 | 35.78 | |
| Depreciation | 102.39 | 64.66 | 51.45 | 37.64 | 44.88 | |
| PAT Before ExtraOrdinary Items Annual Cr | 299.71 | 398.01 | 417.19 | 350.61 | 291.27 | |
| Net Profit Annual | 299.71 | 398.01 | 417.19 | 350.61 | 291.27 | |
| Basic EPS Annual | 22.04 | 29.27 | 30.70 | 25.82 | 21.23 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 2524.02 | 2221.88 | 1918.11 | 1575.47 | 1299.70 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 563.77 | 278.00 | 65.62 | 34.88 | 33.99 | |
| Total Current Liabilities Annual Cr | 2261.78 | 283.77 | 166.24 | 144.46 | 149.44 | |
| Total Capital Plus Liabilities Annual Cr | 5349.57 | 2783.66 | 2150.42 | 1754.80 | 1483.13 | |
| Fixed Assets Annual | 1516.17 | 898.16 | 644.99 | 585.88 | 605.01 | |
| Total Non Current Assets Annual | 3473.02 | 2231.58 | 1570.41 | 1331.17 | 1033.53 | |
| Total Current Assets Annual | 1876.55 | 552.08 | 580.01 | 423.63 | 449.60 | |
| Total Assets Annual | 5349.57 | 2783.66 | 2150.42 | 1754.80 | 1483.13 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 26.23 | 27.23 | 21.21 | 15.81 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 336.29 | 322.33 | 369.41 | 395.41 | 265.19 | |
| Cash from Investing Activity Annual | -2491.89 | -513.30 | -267.64 | -347.86 | 126.80 | |
| Cash from Financing Annual Activity | 2160.05 | 193.75 | -88.42 | -81.13 | -333.52 | |
| Net Cash Flow Annual | - | 2.78 | 13.36 | -33.58 | 58.47 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 185.55 | 163.39 | 141.11 | 116.03 | 95.72 | |
| ROE Annual % | 11.87 | 17.91 | 21.75 | 22.25 | 22.41 | |
| ROCE Annual % | 12.50 | 18.30 | 23.26 | 24.19 | 24.40 | |
| Total Debt to Total Equity Annual | 1.00 | 0.14 | 0.00 | 0.00 | 0.00 | |
| EBDIT Annual Margin % | 32.86 | 39.25 | 42.19 | 38.53 | 36.29 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 566.07 | 490.49 | 508.78 | 467.61 | 403.80 | 425.50 | 465.68 | 401.32 | 314.01 | 337.33 | 366.66 | |
| Operating Expenses Qtr | 402.49 | 310.79 | 324.15 | 296.88 | 283.90 | 286.06 | 309.06 | 269.38 | 209.05 | 210.44 | 219.85 | |
| Operating Profit Qtr | 148.43 | 175.51 | 181.14 | 169.75 | 118.89 | 137.20 | 151.45 | 129.21 | 96.89 | 121.72 | 139.82 | |
| EBIDT Qtr Cr | 163.58 | 179.71 | 184.62 | 170.73 | 119.90 | 139.44 | 156.62 | 131.94 | 104.96 | 126.90 | 146.81 | |
| Depreciation Qtr | 53.90 | 45.72 | 42.09 | 40.89 | 35.13 | 29.90 | 28.62 | 23.44 | 18.36 | 16.88 | 14.96 | |
| Net Profit Qtr | 70.96 | 102.74 | 123.43 | 94.86 | 65.42 | 101.86 | 119.38 | 94.58 | 80.30 | 100.77 | 118.39 | |
| Basic EPS Qtr | 5.22 | 7.55 | 9.08 | 6.97 | 4.81 | 7.49 | 8.84 | 6.96 | 5.91 | 7.41 | 8.71 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 2032.96 | 1696.30 | 1373.14 | 1220.57 | 1089.45 | |
| Operating Expenses Annual Cr | 1334.31 | 1148.40 | 862.09 | 781.29 | 705.68 | |
| Operating Profit Annual | 674.83 | 536.75 | 484.95 | 430.58 | 368.37 | |
| Operating Profit Margin Annual % | 33.19 | 31.64 | 35.32 | 35.28 | 33.81 | |
| Total Expenses Annual Cr | 1601.72 | 1291.66 | 930.94 | 826.07 | 758.11 | |
| EBIDT Annual Cr | 698.64 | 547.90 | 511.05 | 439.28 | 383.77 | |
| EBIDT Annual margin % | 34.37 | 32.30 | 37.22 | 35.99 | 35.23 | |
| Depreciation | 182.60 | 117.09 | 64.70 | 42.98 | 50.26 | |
| PAT Before ExtraOrdinary Items Annual Cr | 397.05 | 374.16 | 405.79 | 355.13 | 296.51 | |
| Net Profit Annual | 391.98 | 382.16 | 406.11 | 355.13 | 296.50 | |
| Basic EPS Annual | 28.79 | 28.10 | 29.89 | 26.14 | 21.59 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 2586.12 | 2195.99 | 1907.86 | 1576.42 | 1296.33 | |
| Minority Interest Liability Annual Cr | 635.91 | 24.69 | -0.11 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 1294.73 | 1003.42 | 164.29 | 91.43 | 91.28 | |
| Total Current Liabilities Annual Cr | 2532.08 | 443.23 | 199.65 | 166.93 | 164.69 | |
| Total Capital Plus Liabilities Annual Cr | 7048.84 | 3667.33 | 2272.14 | 1834.78 | 1552.31 | |
| Fixed Assets Annual | 3485.98 | 2257.97 | 851.46 | 761.95 | 785.75 | |
| Total Non Current Assets Annual | 4746.76 | 2902.61 | 1644.81 | 1367.73 | 1072.69 | |
| Total Current Assets Annual | 2302.07 | 764.72 | 627.33 | 467.05 | 479.62 | |
| Total Assets Annual | 7048.84 | 3667.33 | 2272.14 | 1834.78 | 1552.31 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 31.23 | 27.40 | 19.60 | 17.09 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 486.01 | 291.74 | 378.26 | 375.36 | 271.11 | |
| Cash from Investing Activity Annual | -1827.56 | -982.10 | -319.61 | -323.36 | 123.29 | |
| Cash from Financing Annual Activity | 1379.78 | 688.02 | -44.70 | -82.39 | -334.59 | |
| Net Cash Flow Annual | - | -2.34 | 13.96 | -30.39 | 59.81 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 236.86 | 163.30 | 140.35 | 116.10 | 95.47 | |
| ROE Annual % | 15.15 | 17.40 | 21.28 | 22.52 | 22.87 | |
| ROCE Annual % | 11.42 | 13.36 | 21.53 | 23.76 | 24.03 | |
| Total Debt to Total Equity Annual | 1.06 | 0.38 | 0.02 | 0.00 | 0.00 | |
| EBDIT Annual Margin % | 34.77 | 32.51 | 37.93 | 36.24 | 35.73 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Hdfc Small Cap Fund | 6.6 | 75055275 | - | - |
| Franklin India Smaller Companies Fund | 1.46 | 75055277 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Amit Indubhushan Bakshi | 42.88 | 75055213 | 14.02 | 0 |
| Inderjeet Singh Negi | 4.37 | 75055214 | 31.69 | 0 |
| Rajendrakumar Rambhai Patel | 4.37 | 75055215 | 31.69 | 0 |
| Kaushal Kamleshkumar Shah | 3.29 | 75055216 | 42.13 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Hdfc Small Cap Fund | 6.6 | 75055275 |
| Uti Flexi Cap Fund | 4.14 | 75055276 |
| Franklin India Smaller Companies Fund | 1.46 | 75055277 |
| Emerald Investments Limited | 7.27 | 75055283 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Rakesh Shah | 4.88 | 75055293 |
| Bhikhalal Chimanlal Shah | 2.76 | 75055294 |
| Hetal Rasiklal Shah | 2.58 | 75055295 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Aug 11, 2022 | 7.35 | INTERIM | Aug 16, 2022 | Equity Share |
| Aug 05, 2021 | 6.01 | INTERIM | Aug 06, 2021 | Equity Share |
| Aug 13, 2020 | 5.5 | INTERIM | Aug 14, 2020 | Equity Share |
| Mar 19, 2020 | 2.87 | INTERIM | Mar 20, 2020 | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 21, 2024 | Audited Results & Fund Raising | - |
| Feb 13, 2024 | Quarterly Results | - |
| Nov 08, 2023 | Quarterly Results | - |
| Aug 07, 2023 | Quarterly Results | - |
| May 17, 2023 | Audited Results | - |
| Jan 17, 2023 | Quarterly Results | - |
| Oct 20, 2022 | Quarterly Results | - |
| Aug 05, 2022 | Quarterly Results & Interim Dividend | - |
| May 03, 2022 | Audited Results | - |
| Jan 28, 2022 | Quarterly Results | - |
| Oct 29, 2021 | Quarterly Results | - |
| Jul 29, 2021 | Quarterly Results & Interim Dividend | - |
| May 13, 2021 | Audited Results | - |
| Jan 28, 2021 | Quarterly Results | - |
| Nov 03, 2020 | Quarterly Results | - |
| Aug 04, 2020 | Quarterly Results & Interim Dividend | - |
| Jun 26, 2020 | Audited Results | - |
| Jun 02, 2020 | Quarterly Results | - |
| Mar 11, 2020 | Interim Dividend | - |
| Feb 14, 2020 | Quarterly Results | - |
| Nov 07, 2019 | Quarterly Results | - |
| Jul 27, 2019 | Quarterly Results | - |
| Jul 03, 2019 | Buy Back of Shares | To consider buyback for equity shares |
| May 21, 2019 | Audited Results | - |
| Jan 29, 2019 | Quarterly Results | - |
| Nov 03, 2018 | Quarterly Results | - |
| Aug 09, 2018 | Quarterly Results | - |
| May 25, 2018 | Audited Results | - |
| Feb 12, 2018 | Quarterly Results | - |
| Nov 18, 2017 | Quarterly Results | - |
| Aug 17, 2017 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
04 Jul 2024
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
26 Jun 2024
Eris Lifesciences Ltd - 540596 - Closure of Trading Window
Intimation of Closure of trading window
24 Jun 2024
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of Shares under ESOP 2017 and ESOP 2021 Scheme
11 Jun 2024
Eris Lifesciences Ltd - 540596 - CLOSURE ON ACQUISITION OF 19% EQUITY STAKE IN SWISS PARENTERALS LIMITED
Closure on acquisition of 19% equity stake in Swiss Parenterals Limited
11 Jun 2024
Eris Lifesciences Ltd - 540596 - REDEMPTION OF COMMERCIAL PAPERS ISSUED BY THE COMPANY
Redemption of Commercial Papers issued by the Company
10 Jun 2024
Eris Lifesciences Ltd - 540596 - Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Announcement under regulation 30 of SEBI (LODR) Regulations, 2015
31 May 2024
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
29 May 2024
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Credit Rating
Update on Credit Rating
